Key Takeaways SYM posted Q4 EPS of 53 cents, beating estimates and rising sharply from 5 cents a year earlier. Revenues grew year over year to $618.5M, with a$22.5B backlog boosted by Medline and project pricing. SYM faces valuation, momentum and customer concentration risks despite solid free cash flow and margins. Symbotic (SYM) reported fourth-quarter fiscal 2025 (ended Sept. 30, 2025) results on Nov. 24, after market close. The company, which is a key player in the Zacks Technology Services industry, r ...